We further analyzed the data from the TCGA data set by TIMER2.0 web, and the results showed that the expression of WDR6 was markedly increased in Cholangio carcinoma (CHOL), Colon adenocarcinoma (COAD), Head and Neck squamous cell carcinoma (HNSC), Liver hepatocellular carcinoma (LIHC), Prostate adenocarcinoma (PRAD), Stomach adenocarcinoma (STAD), and Thyroid carcinoma (THCA), compared to normal tissues, but was obviously decreased in LUSC and Kidney renal clear cell carcinoma (KIRC) (Figure 1B). Here, WDR6 is linked to prostate adenocarcinoma.